NCM
CNCE

Nantahala Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Nantahala Capital Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,732,388
Closed -$10.1M – 125
2022
Q4 		$10.1M Sell
1,732,388
-54,771
-3% -$320K 0.66% 29
2022
Q3 		$12M Buy
1,787,159
+127,319
+8% +$853K 0.77% 27
2022
Q2 		$6.99M Buy
+1,659,840
New +$6.99M 0.35% 40